In addition, treatment with recombinant decoy receptor for FasL, which consisted of the extracellular region of mouse Fas fused with the Fc region of human IgG (Fas-Fc) protected B6 mice against lethal infection of PR/8 virus in a dose dependent manner (Fig. 1B). Here, FASLG is linked to infection.